1. Home
  2. PLUR vs SDST Comparison

PLUR vs SDST Comparison

Compare PLUR & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • SDST
  • Stock Information
  • Founded
  • PLUR 2001
  • SDST 2022
  • Country
  • PLUR Israel
  • SDST United States
  • Employees
  • PLUR N/A
  • SDST N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • SDST Blank Checks
  • Sector
  • PLUR Health Care
  • SDST Finance
  • Exchange
  • PLUR Nasdaq
  • SDST Nasdaq
  • Market Cap
  • PLUR 37.6M
  • SDST 34.3M
  • IPO Year
  • PLUR N/A
  • SDST N/A
  • Fundamental
  • Price
  • PLUR $4.48
  • SDST $3.94
  • Analyst Decision
  • PLUR Strong Buy
  • SDST Buy
  • Analyst Count
  • PLUR 1
  • SDST 2
  • Target Price
  • PLUR $12.00
  • SDST $17.00
  • AVG Volume (30 Days)
  • PLUR 9.3K
  • SDST 353.0K
  • Earning Date
  • PLUR 11-11-2025
  • SDST 11-12-2025
  • Dividend Yield
  • PLUR N/A
  • SDST N/A
  • EPS Growth
  • PLUR N/A
  • SDST N/A
  • EPS
  • PLUR N/A
  • SDST N/A
  • Revenue
  • PLUR $1,336,000.00
  • SDST N/A
  • Revenue This Year
  • PLUR $246.11
  • SDST N/A
  • Revenue Next Year
  • PLUR $169.62
  • SDST N/A
  • P/E Ratio
  • PLUR N/A
  • SDST N/A
  • Revenue Growth
  • PLUR 309.82
  • SDST N/A
  • 52 Week Low
  • PLUR $3.33
  • SDST $1.43
  • 52 Week High
  • PLUR $7.13
  • SDST $91.90
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 46.99
  • SDST 75.14
  • Support Level
  • PLUR $4.08
  • SDST $2.98
  • Resistance Level
  • PLUR $4.50
  • SDST $4.31
  • Average True Range (ATR)
  • PLUR 0.22
  • SDST 0.34
  • MACD
  • PLUR -0.02
  • SDST 0.02
  • Stochastic Oscillator
  • PLUR 65.05
  • SDST 79.25

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About SDST Stardust Power Inc. Common Stock

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

Share on Social Networks: